IRM Energy Promoters File No-Encumbrance Declaration for Financial Year 2025-26 Under SEBI Takeover Regulations
The promoters of IRM Energy Limited—Dr. Rajiv I Modi, Cadila Pharmaceuticals Limited, and IRM Trust—filed separate declarations on April 02, 2026, confirming no encumbrance was created, directly or indirectly, on any shares of the company during the financial year 2025-26. The declarations were submitted pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, to the National Stock Exchange of India Limited, BSE Limited, and the company's Audit Committee. Each declaration also covered persons acting in concert (PAC) associated with the respective promoter entities.

*this image is generated using AI for illustrative purposes only.
The promoters of IRM Energy Limited have submitted formal declarations dated April 02, 2026, to the stock exchanges and the company's Audit Committee, confirming the absence of any encumbrance on the company's shares during the financial year 2025-26. The filings were made in compliance with Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Regulatory Background
Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, mandates that promoters and persons acting in concert (PAC) of listed companies declare, on an annual basis, whether any encumbrance has been created on the shares held by them. These declarations are submitted to the relevant stock exchanges and the company's Audit Committee as part of ongoing disclosure obligations.
Promoters Filing the Declaration
Three promoter entities of IRM Energy Limited independently filed their respective no-encumbrance declarations for the financial year 2025-26. The details of each declarant are presented below:
| Declarant: | Capacity | Declaration Date |
|---|---|---|
| Dr. Rajiv I Modi | Promoter (Individual) | April 02, 2026 |
| Cadila Pharmaceuticals Limited | Promoter (Corporate Entity) | April 02, 2026 |
| IRM Trust | Promoter (Trust) | April 02, 2026 |
Key Declarations
Each of the three promoter entities confirmed the following in their respective filings:
- No encumbrance, direct or indirect, was created on any shares of IRM Energy Limited during the financial year 2025-26.
- The declaration covers the promoter entity as well as all persons acting in concert (PAC) associated with them.
- The filings were addressed to the National Stock Exchange of India Limited and BSE Limited, along with the Audit Committee of IRM Energy Limited.
Dr. Rajiv I Modi filed the declaration in his individual capacity as promoter of IRM Energy Limited. Cadila Pharmaceuticals Limited, a corporate promoter entity, submitted its declaration signed by Dr. Rajiv I. Modi in his capacity as Managing Director. IRM Trust, the third promoter entity, filed its declaration through Dr. Rajiv I. Modi acting as Managing Trustee.
Submission Details
All three declarations were submitted to the stock exchanges on April 02, 2026. The filings were directed to both the National Stock Exchange of India Limited at Exchange Plaza, Bandra-Kurla Complex, Mumbai, and BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai. Copies were also addressed to the Audit Committee of IRM Energy Limited at its registered office at Magnet Corporate Park, S. G. Highway, Ahmedabad.
Historical Stock Returns for IRM Energy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.38% | -10.24% | +76.55% | +6.11% | +16.89% | -32.26% |
How might IRM Energy's clean promoter shareholding record influence institutional investor confidence and potential foreign portfolio investment in the company going forward?
Given Cadila Pharmaceuticals' role as a corporate promoter, could any strategic restructuring or divestment plans at the parent company level impact IRM Energy's ownership structure in the near future?
As IRM Energy operates in the city gas distribution sector, how could upcoming regulatory changes in India's natural gas pricing or CGD licensing rounds affect the promoters' long-term shareholding strategy?


































